Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
HALOZYME THERAPEUTICS, INC. (HALO)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
27 Feb 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
156,558
-11%
20,000
$39.75
$794,923.00
SELL
16 Jan 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
151,911
-11%
20,000
$36.00
$720,000.00
SELL
14 Nov 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
151,911
-11%
20,000
$39.43
$788,670.00
SELL
19 Sep 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
151,911
-6%
10,000
$39.10
$390,980.00
SELL
29 Aug 2023
Torley Helen
PRESIDENT AND CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
623,666
-4%
30,000
$42.69
$1,280,730.00
SELL
22 Aug 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
151,911
-6%
10,000
$42.41
$424,070.00
SELL
15 Aug 2023
Torley Helen
PRESIDENT AND CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
623,666
-4%
30,000
$43.49
$1,304,820.00
SELL
11 Aug 2023
Daly James M
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
20,503
-49%
20,000
$43.73
$874,520.00
SELL
25 Jul 2023
Torley Helen
PRESIDENT AND CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
623,666
-4%
30,000
$43.09
$1,292,750.00
SELL
12 Jul 2023
Daniel Goldman
Congressman (House)
HALOZYME THERAPEUTICS, INC.
(HALO)
N/A
N/A
N/A
$15,001 - 50,000
SELL
21 Jun 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
141,911
-6%
10,000
$36.00
$360,000.00
SELL
18 Apr 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
141,911
-6%
10,000
$36.00
$360,000.00
SELL
28 Feb 2023
Henderson Jeffrey William
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
39,045
-33%
20,000
$48.11
$962,200.00
SELL
27 Feb 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
141,911
-6%
10,000
$49.55
$495,483.00
SELL
27 Feb 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
141,911
-2%
2,984
$49.55
$147,854.22
SELL
16 Feb 2023
Torley Helen
PRESIDENT AND CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
633,666
-1%
11,061
$49.26
$544,864.80
SELL
16 Feb 2023
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
9,066
-21%
2,525
$49.26
$124,381.49
SELL
16 Feb 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
148,927
-1%
2,878
$49.26
$141,770.28
SELL
15 Feb 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
143,477
-6%
10,000
$48.39
$483,940.00
SELL
7 Feb 2023
Torley Helen
PRESIDENT AND CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
587,177
-4%
30,000
$51.01
$1,530,150.00
SELL
17 Jan 2023
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
144,259
-6%
10,000
$50.46
$504,590.20
SELL
17 Jan 2023
Torley Helen
PRESIDENT AND CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
587,177
-4%
30,000
$51.30
$1,539,149.00
SELL
13 Dec 2022
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
158,202
-5%
10,000
$58.67
$586,674.56
SELL
13 Dec 2022
Torley Helen
PRESIDENT AND CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
588,073
-4%
30,000
$58.11
$1,743,301.80
SELL
2 Dec 2022
Posard Matthew L.
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
105,189
-22%
30,000
$56.89
$1,706,550.00
SELL
15 Nov 2022
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
166,260
-5%
10,000
$54.13
$541,263.06
SELL
15 Nov 2022
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
4,410
-53%
5,000
$53.81
$269,052.56
SELL
15 Nov 2022
Torley Helen
PRESIDENT AND CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
587,177
-4%
30,000
$53.39
$1,601,626.40
SELL
5 Aug 2022
Josh Gottheimer
Congressman (House)
HALOZYME THERAPEUTICS, INC.
(HALO)
N/A
N/A
N/A
$1,001 - $15,000
SELL
8 Nov 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
549,385
-8%
50,000
$39.82
$1,990,767.80
SELL
5 Nov 2021
MATSUI CONNIE
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
194,531
-14%
32,000
$40.38
$1,292,112.90
SELL
4 Oct 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
543,017
-8%
50,000
$40.09
$2,004,389.90
SELL
1 Oct 2021
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
148,796
-16%
29,450
$39.93
$1,175,968.00
SELL
7 Sep 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
543,720
-8%
50,000
$42.38
$2,118,846.00
SELL
25 Aug 2021
BIZZARI JEAN-PIERRE
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
52,544
-39%
35,000
$41.01
$1,435,455.00
BUY
20 Aug 2021
Josh Gottheimer
Congressman (House)
HALOZYME THERAPEUTICS, INC.
(HALO)
N/A
N/A
N/A
$1,001 - $15,000
SELL
10 Aug 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
562,022
-8%
50,000
$41.11
$2,055,576.00
SELL
6 Jul 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
537,160
-8%
50,000
$45.97
$2,298,650.00
SELL
1 Jul 2021
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
134,111
-23%
40,315
$45.70
$1,842,315.00
SELL
7 Jun 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
537,160
-8%
50,000
$39.66
$1,982,950.00
SELL
11 May 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
578,704
-7%
50,000
$43.02
$2,151,098.80
SELL
14 Apr 2021
Kelley Kenneth J
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
179,833
-2%
5,000
$45.00
$225,000.00
SELL
5 Apr 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
537,160
-8%
50,000
$42.55
$2,127,250.00
SELL
1 Apr 2021
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
141,794
-16%
28,689
$42.56
$1,221,037.10
SELL
1 Mar 2021
Kelley Kenneth J
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
185,333
-2%
5,000
$45.34
$226,717.40
SELL
1 Mar 2021
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
129,330
-12%
18,324
$45.81
$839,363.60
SELL
1 Mar 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
571,050
-8%
50,000
$46.19
$2,309,454.50
SELL
1 Feb 2021
Kelley Kenneth J
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
190,079
-2%
5,000
$48.12
$240,593.95
SELL
1 Feb 2021
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
475,959
-9%
50,000
$47.84
$2,391,917.50
SELL
4 Jan 2021
Kelley Kenneth J
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
195,123
-2%
5,000
$42.91
$214,555.58
SELL
21 Dec 2020
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
123,400
-8%
12,000
$42.58
$510,918.60
SELL
7 Dec 2020
Kelley Kenneth J
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
199,833
-14%
35,086
$41.00
$1,438,526.00
SELL
2 Dec 2020
Kelley Kenneth J
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
234,919
-11%
31,792
$41.00
$1,303,472.00
SELL
25 Nov 2020
Henderson Jeffrey William
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
47,609
-33%
24,498
$40.08
$981,757.40
SELL
25 Nov 2020
Kelley Kenneth J
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
266,711
-6%
19,671
$41.37
$813,850.40
SELL
25 Nov 2020
Daly James M
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
21,002
-33%
10,363
$40.41
$418,799.90
SELL
25 Nov 2020
Torley Helen
President and CEO, Director, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
508,196
-8%
50,000
$40.73
$2,036,567.80
SELL
20 Nov 2020
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
142,689
-7%
12,000
$38.76
$465,176.06
BUY
22 Oct 2020
Gilbert Cisneros
Congressman (House)
HALOZYME THERAPEUTICS, INC.
(HALO)
N/A
N/A
N/A
$1,001 - $15,000
SELL
20 Oct 2020
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
146,800
-7%
12,000
$30.43
$365,148.00
BUY
19 Oct 2020
Josh Gottheimer
Congressman (House)
HALOZYME THERAPEUTICS, INC.
(HALO)
N/A
N/A
N/A
$1,001 - $15,000
SELL
21 Sep 2020
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
158,800
-7%
12,000
$26.91
$322,884.00
SELL
11 Sep 2020
MATSUI CONNIE
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
216,753
-12%
32,000
$27.06
$865,792.00
SELL
20 Aug 2020
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
170,800
-6%
12,000
$28.30
$339,564.00
SELL
13 Aug 2020
Daly James M
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
31,365
-52%
34,337
$29.12
$999,893.50
SELL
20 Jul 2020
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
182,800
-6%
12,000
$29.01
$348,072.00
SELL
20 May 2020
LaBarre Michael J.
SVP, Chief Technical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
176,187
-10%
21,387
$23.80
$509,074.75
BUY
19 Mar 2020
Kelley Kenneth J
Director
HALOZYME THERAPEUTICS, INC.
(HALO)
242,467
+27%
52,629
$14.23
$748,696.60
SELL
3 Aug 2019
Chondros Dimitrios
SVP, Chief Medical Officer, Officer
HALOZYME THERAPEUTICS, INC.
(HALO)
38,584
-3%
1,328
$16.70
$22,177.60
SELL
24 Aug 2018
KIRK RANDAL J
10% Owner
HALOZYME THERAPEUTICS INC
(HALO)
3,900,919
-14%
644,998
$18.08
$11,663,346.00
SELL
21 Aug 2018
KIRK RANDAL J
10% Owner
HALOZYME THERAPEUTICS INC
(HALO)
4,162,633
-22%
1,194,462
$17.65
$21,085,138.00
SELL
14 Aug 2018
KIRK RANDAL J
10% Owner
HALOZYME THERAPEUTICS INC
(HALO)
4,643,451
-9%
490,072
$17.30
$8,476,983.00
SELL
8 Aug 2018
KIRK RANDAL J
10% Owner
HALOZYME THERAPEUTICS INC
(HALO)
4,842,304
-10%
572,804
$17.35
$9,937,299.00
SELL
25 Jul 2018
KIRK RANDAL J
10% Owner
HALOZYME THERAPEUTICS INC
(HALO)
5,074,726
-5%
302,827
$17.24
$5,221,414.50
SELL
27 Jun 2018
KIRK RANDAL J
10% Owner
HALOZYME THERAPEUTICS INC
(HALO)
5,197,602
-5%
304,321
$17.04
$5,186,692.00
SELL
6 Nov 2017
Mark Warner
Congressman (Senate)
HALOZYME THERAPEUTICS, INC.
(HALO)
N/A
N/A
N/A
$500,001 - $1,000,001
Home